External broker reports(aggregated public sources), HDFC Securities

HDFC Securities

External broker reports(aggregated public sources)

HDFC securities is the best online trading platform for stocks, IPOs, mutual fund in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Thematic (Sector/Industry)

<ul><li>ITC: ITC delivered a strong revenue and EBITDA growth and the beat was largely on account of a sharp jump in the non-cigarette business</li><li>Cigarette revenue growth was a marginal beat at 29% YoY (HSIE 27%, 7% three-year CAGR)</li><li>Cigarette volume growth was at ~26% (2% three-year CAGR)</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

ITC: ITC delivered a strong revenue and EBITDA growth and the beat was largely on account of a sharp jump in the non-cigarette businessCigarette revenue growth was a marginal beat at 29% YoY (HSIE 27%, 7% three-year CAGR)Cigarette volume growth was at ~26% (2% three-year CAGR)Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HSIE Results Daily: ITC, NTPC, Ashok Leyland, The Ramco Cements, Alkyl Amines

HSIE Results Daily: ITC, NTPC, Ashok Leyland, The Ramco Cements

<div><div><div><ul><li>Ashok Leyland: In Q4, Ashok Leyland’s (AL) margin improved 130bps YoY to 8.9%, led by (1) 11% YoY volume growth and (2) 13% YoY realisation growth.</li><li>Alkyl Amines: We maintain SELL on Alkyl Amines with a price target of INR 2,375 (WACC 11%, terminal growth 5%).</li></ul></div></div></div><div><div><div><div><div><div><ul><li>Prince Pipes: We maintain BUY on Prince Pipes with a revised target price of INR 875/sh (18.5x its Mar-24E EBITDA).</li></ul></div></div></div></div></div></div><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Ashok Leyland: In Q4, Ashok Leyland’s (AL) margin improved 130bps YoY to 8.9%, led by (1) 11% YoY volume growth and (2) 13% YoY realisation growth.Alkyl Amines: We maintain SELL on Alkyl Amines with a price target of INR 2,375 (WACC 11%, terminal growth 5%).Prince Pipes: We maintain BUY on Prince Pipes with a revised target price of INR 875/sh (18.5x its Mar-24E EBITDA).Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HSIE Results Daily: Ashok Leyland, Alkyl Amines, Prince Pipes

Equity Bottom-Up

Alkyl Amines Chemicals / Equity Bottom-Up

<ul><li>We downgrade Alkyl Amines (AACL) from a REDUCE to a SELL, with a price target of INR 2,100 (WACC 12%, terminal growth 5%)</li><li>The dumping of products by Chinese chemical manufacturers has resulted in a sharp correction in the prices of key products of the company</li><li>AACL has to pass on the benefit of falling raw material prices to its customers in the coming quarters in order to retain its market share</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

We downgrade Alkyl Amines (AACL) from a REDUCE to a SELL, with a price target of INR 2,100 (WACC 12%, terminal growth 5%)The dumping of products by Chinese chemical manufacturers has resulted in a sharp correction in the prices of key products of the companyAACL has to pass on the benefit of falling raw material prices to its customers in the coming quarters in order to retain its market shareContent is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Alkyl Amines: Testing Times Ahead. Downgrade to SELL

<p>HSIE Results Daily Dabur: Daburs Q1 performance was inspiring with a beat in revenue, volume and EBITDA. Revenue growth was at 32% YoY (HSIE 22%), 2-year CAGR at 7%. Domestic revenue/volume growth were at 35/34% YoY, 2-year CAGR at 12/10% vs. Britannias 12/13%, Nestles 8/6%, Maricos 7/2%, Colgates 4/0%, Emamis 3/2% and HULs 2/0%. Daburs healthcare/HPC/F&amp;B; grew 30/26/80% YoY (vs. +29/-15/-34% in Q1FY21 and +23/+33/+28% in Q4FY21). The international business saw continued recovery, growing 29% YoY.</p><div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

HSIE Results Daily Dabur: Daburs Q1 performance was inspiring with a beat in revenue, volume and EBITDA. Revenue growth was at 32% YoY (HSIE 22%), 2-year CAGR at 7%. Domestic revenue/volume growth were at 35/34% YoY, 2-year CAGR at 12/10% vs. Britannias 12/13%, Nestles 8/6%, Maricos 7/2%, Colgates 4/0%, Emamis 3/2% and HULs 2/0%. Daburs healthcare/HPC/F&amp;B; grew 30/26/80% YoY (vs. +29/-15/-34% in Q1FY21 and +23/+33/+28% in Q4FY21). The international business saw continued recovery, growing 29% YoY.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HSIE Results Daily: Dabur, Godrej Properties, Alkyl Amines and More

India

Alkyl Amines Chemicals Limited manufactures and supplies aliphatic amines, amine derivatives, and specialty chemicals. Its products serve various industries including pharmaceuticals, agrochemicals, water treatment, and rubber chemicals. The company was established in 1979 and is headquartered in Navi Mumbai, India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Alkyl Amines Chemicals (AACL IN)

HSIE Results Daily: ITC, NTPC, Ashok Leyland, The Ramco Cements, Alkyl Amines

ITC: ITC delivered a strong revenue and EBITDA growth and the beat was largely on account of a sharp jump in the non-cigarette business

HDFC Securities

HSIE Results Daily: ITC, NTPC, Ashok Leyland, The Ramco Cements

ITC: ITC delivered a strong revenue and EBITDA growth and the beat was largely on account of a sharp jump in the non-cigarette business

HDFC Securities

HSIE Results Daily: Ashok Leyland, Alkyl Amines, Prince Pipes

Ashok Leyland: In Q4, Ashok Leyland’s (AL) margin improved 130bps YoY to 8.9%, led by (1) 11% YoY volume growth and (2) 13% YoY realisation growth.

HDFC Securities

Alkyl Amines: Testing Times Ahead. Downgrade to SELL

We downgrade Alkyl Amines (AACL) from a REDUCE to a SELL, with a price target of INR 2,100 (WACC 12%, terminal growth 5%)

HDFC Securities

HSIE Results Daily: Dabur, Godrej Properties, Alkyl Amines and More

Dabur: Daburs Q1 performance was inspiring with a beat in revenue, volume and EBITDA. Revenue growth was at 32% YoY (HSIE 22%), 2-year CAGR at 7%....

HDFC Securities

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)